Results 31 to 40 of about 9,557,066 (249)

Advanced Glycation End Products As Biomarkers in Systemic Diseases: Premises and Perspectives of Salivary Advanced Glycation End Products [PDF]

open access: yesBiomarkers in Medicine, 2019
Advanced glycation end products (AGEs) are glycated proteins associated with high dry temperature food processing, coloring and flavor modification of food products. Previous studies on diet-related disease support the role of the glycation products as biomarkers in local and general proinflammatory response.
Babtan A. M.   +8 more
openaire   +3 more sources

HMGB-1 - a novel mediator of inflammatory-induced renal epithelial mesenchymal transition [PDF]

open access: yes, 2010
Background: High mobility group box protein 1 (HMGB-1) is a chromatin binding protein that bends DNA thereby facilitating gene transcription. HMGB-1 has also been observed as an extracellular secreted protein in serum of patients with sepsis and has ...
Ryan, Michael P.   +11 more
core   +1 more source

The Role of Advanced Glycation End Products on Dyslipidemia [PDF]

open access: yesMetabolites, 2023
Disorders of lipoprotein metabolism and glucose homeostasis are common consequences of insulin resistance and usually co-segregate in patients with metabolic syndrome and type 2 diabetes mellitus (DM). Insulin-resistant subjects are characterized by atherogenic dyslipidemia, a specific lipid pattern which includes hypertriglyceridemia, reduced high ...
Jelena Vekic   +8 more
openaire   +5 more sources

Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults

open access: yesMedicines, 2018
Background: Consumption of dietary advanced glycation end products is linked to metabolic syndrome. The objective was to describe the association between dietary advanced glycation end products intake and metabolic syndrome in young Mexican adults ...
Kenny Mendoza-Herrera   +5 more
doaj   +1 more source

Zinc against advanced glycation end products [PDF]

open access: yesClinical and Experimental Pharmacology and Physiology, 2018
Summary Advanced glycation end products ( AGE s) are destructive compounds with pathogenic importance in age‐related chronic diseases. Zinc has antioxidant, anti‐inflammatory and anti‐apoptotic potential.
Sorayya Kheirouri   +2 more
openaire   +2 more sources

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review

open access: yesInternational Archives of Otorhinolaryngology, 2016
Introduction High mobility group box 1 is a versatile protein involved in gene transcription, extracellular signaling, and response to inflammation. Extracellularly, high mobility group box 1 binds to several receptors, notably the receptor for advanced ...
Austin Nguyen   +4 more
doaj   +1 more source

Advanced Glycation End Products Inhibitor

open access: yes, 2010
Early intensive glycemic control in both type 1 and type 2 diabetes mellitus retards in the long term the development and progression of microvascular complications such as diabetic nephropathy, even despite a worsening glycemic control. This phenomenon is a so-called metabolic memory or legacy effect, partly ascribed to the advanced glycation end ...
Dan, Takashi   +2 more
openaire   +2 more sources

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes [PDF]

open access: yes, 2012
Objective To determine the role of markers of plasma protein damage by glycation, oxidation and nitration in microalbuminuria onset or subsequent decline of glomerular filtration rate (termed “early GFR decline”) in patients with type 1 diabetes ...
Weston Andrew   +35 more
core   +1 more source

Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2010
Background Levels of pentosidine (representative of advanced glycation end-products) in sera of patients with rheumatoid arthritis are increased when compared with sera of other diagnoses or healthy controls.
Vilím Vladimír   +2 more
doaj   +1 more source

Leukocytes in type 1 diabetes mellitus: the changes they undergo and induce

open access: yesБіологічні студії, 2022
As leukocytes represent cellular and humoral immunity at the same time, they are a vital part of every immune process. This also stands for autoimmune processes and disorders, such as diabetes, specifically type 1 diabetes mellitus.
О. М. Kuchurka   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy